Activus Pharmaceuticals is an IND-stage drug delivery and formulation company based in Funabashi, Japan. Activus' proprietary platform, APNT (Activus Pure Nanoparticle Technology), has been applied to the ophthalmology disease area in two late-preclinical assets. APNT effectively reduces API particle size to improve solubility and bioavailability without the drawbacks of heavy metal contamination other platforms often experience.
Activus was founded in 2006 as a spin-off from the Dainippon Ink and Chemicals (DIC) Corporation. After being acquired by Sosei Corporation in 2010, Activus was acquired by Formosa Pharmaceuticals in August, 2017.
Company Details
- Founded
- -
- Address
- 1-17-25 Kita-Honcho, Funabashi-Shi,chiba 273-0864,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Łódź.
- HQ
- Funabashi-shi, Chiba
Activus Pharmaceuticals Questions
Activus Pharmaceuticals's LinkedIn profile is https://jp.linkedin.com/company/activus-pharmaceuticals
Activus Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Activus Pharmaceuticals's top competitors are
Chromavis Fareva,
Medikoz Medical,
Abbvie,
Sanovel İlaç,
Glohe Group,
The Force Ct Gmbh,
Skinlab By Dr. Jamuna Pai,
Surfactgreen,
Mpr Labs.
Activus Pharmaceuticals's categories are Pharmaceutical Manufacturing
Activus Pharmaceuticals's founding year is 2006
